Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jul;35(7):1495–1497. doi: 10.1128/aac.35.7.1495

Failure of routine susceptibility tests to detect imipenem resistance among strains of methicillin-resistant Staphylococcus aureus.

J M Boyce 1, E Papa 1, R Dickenson 1, A A Medeiros 1
PMCID: PMC245199  PMID: 1929315

Abstract

We tested 75 methicillin-resistant Staphylococcus aureus strains for susceptibility to imipenem by using disk diffusion tests and broth microdilution tests with standard and heavy inocula. Population analysis was performed on isolates that appeared to be susceptible by these methods. All of the strains contained subpopulations of cells that are phenotypically resistant to imipenem.

Full text

PDF
1495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyce J. M., Medeiros A. A., Papa E. F., O'Gara C. J. Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1990 Jan;25(1):73–81. doi: 10.1093/jac/25.1.73. [DOI] [PubMed] [Google Scholar]
  2. Boyce J. M., Medeiros A. A. Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1987 Sep;31(9):1426–1428. doi: 10.1128/aac.31.9.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cherubin C. E., Corrado M. L., Sierra M. F., Gombert M. E., Shulman M. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1981 Oct;20(4):553–555. doi: 10.1128/aac.20.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Debbia E., Varaldo P. E., Schito G. C. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin. Antimicrob Agents Chemother. 1986 Nov;30(5):813–815. doi: 10.1128/aac.30.5.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eliopoulos G. M., Thauvin C., Gerson B., Moellering R. C., Jr In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother. 1985 Mar;27(3):357–362. doi: 10.1128/aac.27.3.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fan W., del Busto R., Love M., Markowitz N., Cendrowski C., Cardenas J., Quinn E., Saravolatz L. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother. 1986 Jan;29(1):26–29. doi: 10.1128/aac.29.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fass R. J., Helsel V. L. In vitro activity of LY146032 against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother. 1986 Nov;30(5):781–784. doi: 10.1128/aac.30.5.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holt H. A., Bywater M. J., Reeves D. S. Activity of penems against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1988 Jul;22(1):87–88. doi: 10.1093/jac/22.1.87. [DOI] [PubMed] [Google Scholar]
  9. Ishag A. J., Durgham S. M., Shibl A. M. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents. Chemioterapia. 1987 Aug;6(4):261–263. [PubMed] [Google Scholar]
  10. Jones R. N., Barry A. L. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob Agents Chemother. 1987 Apr;31(4):625–629. doi: 10.1128/aac.31.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jorgensen J. H., Redding J. S., Maher L. A., Ramirez P. E. Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams. J Clin Microbiol. 1988 Sep;26(9):1675–1678. doi: 10.1128/jcm.26.9.1675-1678.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kropp H., Gerckens L., Sundelof J. G., Kahan F. M. Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis. 1985 Jul-Aug;7 (Suppl 3):S389–S410. doi: 10.1093/clinids/7.supplement_3.s389. [DOI] [PubMed] [Google Scholar]
  13. Markowitz N., Pohlod D. J., Saravolatz L. D., Quinn E. L. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother. 1983 Mar;23(3):450–457. doi: 10.1128/aac.23.3.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maskell J. P., Tang T., Asad S., Williams J. D. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro. J Antimicrob Chemother. 1989 Mar;23 (Suppl 100):65–74. doi: 10.1093/jac/23.suppl_c.65. [DOI] [PubMed] [Google Scholar]
  15. Neu H. C., Chin N. X., Neu N. M. In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Antimicrob Agents Chemother. 1987 Apr;31(4):558–569. doi: 10.1128/aac.31.4.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Piddock L. J., Traynor E. A., Wise R. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins. J Antimicrob Chemother. 1989 Mar;23 (Suppl 100):59–64. doi: 10.1093/jac/23.suppl_c.59. [DOI] [PubMed] [Google Scholar]
  17. Sachdeva M., Hackbarth C., Stella F. B., Chambers H. F. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci. Antimicrob Agents Chemother. 1987 Oct;31(10):1549–1552. doi: 10.1128/aac.31.10.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thompson R. L., Fisher K. A., Wenzel R. P. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1982 Feb;21(2):341–343. doi: 10.1128/aac.21.2.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thornsberry C., McDougal L. K. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983 Nov;18(5):1084–1091. doi: 10.1128/jcm.18.5.1084-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van der Auwera P., Ernst F., Grenier P., Glupczynski Y., Husson M., Klastersky J. In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem. J Antimicrob Chemother. 1987 Aug;20(2):179–189. doi: 10.1093/jac/20.2.179. [DOI] [PubMed] [Google Scholar]
  21. Verbist L., Verhaegen J. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother. 1981 Mar;19(3):402–406. doi: 10.1128/aac.19.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wise R., Andrews J. M., Piddock L. J. In vitro activity of CGP 31608, a new penem. Antimicrob Agents Chemother. 1987 Feb;31(2):267–273. doi: 10.1128/aac.31.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Witte J. L., Sapico F. L., Canawati H. N. In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982 Nov;22(5):906–908. doi: 10.1128/aac.22.5.906. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES